Implantable Medical Devices Market Analysis

Product (Cardiovascular, Ophthalmology, Orthopedic, Plastic Surgery, Dental, Neurology)

Cardiovascular segment is poised to account for more than 31% implantable medical devices market share by the end of 2037 driven by the increasing prevalence of several cardiovascular diseases in the population worldwide. According to a report by the World Health Organization in 2021, it was estimated that more than 17.9 million people died in 2019 attributed to cardiovascular diseases; this data registers a share of about 32% of global deaths.

Additionally, there is also an increase in technological advancements; increasing investments, coupled with the surge in the geriatric population, would help the cardiovascular segment dominate this implantable medical devices market expansion. The increase in such technological advancements has fueled the revenue share while improving the safety features, which makes them a better option for consumers.

Material (Stainless Steel, Titanium, Cobalt-Chromium Alloys, Titanium Alloys, Zirconium)

The stainless-steel segment is estimated to gain a robust implantable medical devices market share owing to the highly durable, resilient, and stable material, which makes it one of the most commonly, used materials for implantable medical devices. Stainless steel is a very resistant material, with a high strength and ability to withstand pressure, making it ideal for use in the human body.

According to a report, stainless steel 304 is regarded globally as the most suited material for the manufacturing of medical devices. Furthermore, stainless steel has a high resistance to corrosion and oxidization, which is a crucial factor in maintaining the long-term stability and reliability of implantable medical devices.

Nature of Device (Active, Passive)

The Active segment in the implantable medical devices market is estimated to exhibit lucrative CAGR till 2037. The reason behind this impact is projected by the increase in several devices such as defibrillators, ventricular assist systems, infusion pumps, pacemakers, and many more.

According to a report by the National Institutes of Health in 2021, from 2012 to 2018 there was an increase in public awareness regarding the knowledge of how to use Automated External Defibrillators (AED) grew from 4.7% to 20.8%.

Our in-depth analysis of the implantable medical devices market includes the following segments:

Product	Cardiovascular Implantable Cardiac Defibrillators [ICDs] Stents Pacemaker Implantable Cardiac Monitors [ICM] Ventricular Assist Devices Cardiac Resynchronization Therapy Devices [CRT]) Ophthalmology Intraocular Lenses Glaucoma Implants Orthopedic Joint Reconstruction Spinal Devices Trauma Fixation Devices Plastic Surgery Breast Implants Gluteal Implants Dental Dental Implants Dental Crowns Abutment Neurology Deep Brain Stimulators
Type	Diagnostic Treatment
Nature of Device	Active Passive
Material	Stainless Steel Titanium Cobalt-Chromium Alloys Titanium Alloys Zirconium

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of implantable medical devices is evaluated at USD 107.8 billion.

The implantable medical devices market size was over USD 102.47 billion in 2024 and is poised to exceed USD 232.35 billion by 2037, growing at over 6.5% CAGR during the forecast period i.e., between 2025-2037. The market growth is due to slated demand for disease detection, early diagnosis, and technological advancements in disease management services.

North America industry is predicted to hold largest revenue share of 43% by 2037, propelled by surge in neurological diseases and cardiovascular diseases, along with the geriatric population in the region.

The major players in the market are Abbott, Boston Scientific Corporation, Zimmer Biomet Holdings, Stryker Corporation, Smith & Nephew plc, Becton, Dickinson, and Company, LivaNova, Edwards Lifesciences, Globus Medical, Inc., and others.

Implantable Medical Devices Market Analysis